Propiedad y actividad de insiders de Day One Biopharmaceuticals, Inc. (DAWN): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $21.53 |
| Capitalización | $2.2B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-04-23 | AI Day1 LLC | U-Tender | 12,929,322 | $278.0M |
| 2026-04-23 | AI Day1 LLC | D-Return | 827,586 | $83 |
| 2026-04-23 | Bender Jeremy | D-Return | 808,285 | $81 |
| 2026-04-23 | Bender Jeremy | D-Return | 286,000 | $2.6M |
| 2026-04-23 | Bender Jeremy | D-Return | 355,000 | $4.0M |
| 2026-04-23 | Bender Jeremy | D-Return | 222,188 | |
| 2026-04-23 | VASCONCELLES MICHAEL | D-Return | 4,397 | $0 |
| 2026-04-23 | VASCONCELLES MICHAEL | D-Return | 346,000 | $2.3M |
| 2026-04-23 | VASCONCELLES MICHAEL | D-Return | 171,000 | $1.9M |
| 2026-04-23 | VASCONCELLES MICHAEL | D-Return | 106,875 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $27.3M | $43.7M | $284.3M | $85.3M | $230.8M | $125.0M | $197.1M |
| Inversiones a Corto | 0 | 0 | 0 | $257.0M | $135.6M | $406.8M | $244.0M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | $13.9M | $26.7M |
| Inventario | 0 | 0 | 0 | 0 | 0 | $3.3M | $6.3M |
| Activos Corrientes | $27.3M | $45.1M | $289.4M | $347.9M | $375.3M | $562.3M | $485.1M |
| Inmovilizado Material | 0 | $483000 | $284000 | $719000 | $560000 | $4.7M | $4.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | $15.6M | $18.0M |
| Activos Totales | $27.3M | $45.7M | $289.8M | $349.1M | $376.0M | $582.8M | $507.8M |
| Cuentas por Pagar | $69000 | $202000 | $1.7M | $260000 | $2.6M | $3.3M | $3.7M |
| Deuda a Corto | 0 | 0 | $204000 | $405000 | $408000 | $10000 | 0 |
| Pasivos Corrientes | $2.0M | $2.0M | $8.7M | $16.6M | $29.5M | $73.5M | $60.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $32.5M | $2.2M | $8.7M | $17.0M | $29.5M | $80.0M | $66.7M |
| Reservas | -$12.8M | -$56.8M | -$127.5M | -$269.7M | -$458.6M | -$554.1M | -$661.4M |
| Patrimonio Neto | -$10.7M | $37.8M | $281.1M | $332.0M | $346.5M | $502.8M | $441.2M |
| Deuda Total | 0 | $402000 | $220000 | $813000 | $408000 | $2.6M | $2.8M |
| Deuda Neta | -$27.3M | -$43.3M | -$284.1M | -$341.5M | -$365.9M | -$529.1M | -$438.3M |
| Capital Circulante | $25.3M | $43.1M | $280.7M | $331.3M | $345.8M | $488.9M | $424.6M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 8.02 |
Rentabilidad
| Rentabilidad sobre capital | -23.43% |
| Rentabilidad sobre capital invertido | -28.03% |
| Rentabilidad sobre activos | -21.13% |
| Margen bruto | 89.12% |
| Margen operativo | -80.76% |
| Margen neto | -67.85% |
Empresas relacionadas: ARVN · ATXS · AVBP · ERAS · GERN · REPL · RZLT
Explorar sector: Healthcare · Biotechnology
Más secciones de DAWN: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones